The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model

被引:35
|
作者
Matsuzaki, Yuichi [1 ]
Iwaki, Ryuma [1 ]
Reinhardt, James W. [1 ]
Chang, Yu-Chun [1 ,2 ]
Miyamoto, Shinka [1 ]
Kelly, John [1 ]
Zbinden, Jacob [1 ,3 ]
Blum, Kevin [1 ,3 ]
Mirhaidari, Gabriel [1 ,2 ]
Ulziibayar, Anudari [1 ]
Shoji, Toshihiro [1 ]
Breuer, Christopher K. [1 ,4 ]
Shinoka, Toshiharu [1 ,4 ,5 ]
机构
[1] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Regenerat Med, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Biomed Engn Grad Program, Columbus, OH 43210 USA
[4] Ohio State Univ, Nationwide Childrens Hosp, Dept Surg, Columbus, OH 43210 USA
[5] Nationwide Childrens Hosp, Heart Ctr, Dept Cardiothorac Surg, 700 Childrens Dr,T2294, Columbus, OH 43205 USA
关键词
Tissue engineering; Vascular graft; Biodegradable; Artery; Pore diameter; Large animal model; VASCULAR GRAFTS; POLARIZATION; FIBERS;
D O I
10.1016/j.actbio.2020.08.011
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To date, there has been little investigation of biodegradable tissue engineered arterial grafts (TEAG) using clinically relevant large animal models. The purpose of this study is to explore how pore size of electrospun scaffolds can be used to balance neoarterial tissue formation with graft structural integrity under arterial environmental conditions throughout the remodeling process. TEAGs were created with an outer poly-epsilon-caprolactone (PCL) electrospun layer and an inner sponge layer composed of heparin conjugated 50:50 poly (l-lactide-co-epsilon-caprolactone) copolymer (PLCL). Outer electrospun layers were created with four different pore diameters (4, 7, 10, and 15 mu m). Fourteen adult female sheep underwent bilateral carotid artery interposition grafting (n = 3-4 /group). Our heparin-eluting TEAG was implanted on one side (n = 14) and ePTFE graft (n = 3) or non-heparin-eluting TEAG (n = 5) on the other side. Twelve of the fourteen animals survived to the designated endpoint at 8 weeks, and one animal with 4 mu m pore diameter graft was followed to 1 year. All heparin-eluting TEAGs were patent, but those with pore diameters larger than 4 mu m began to dilate at week 4. Only scaffolds with a pore diameter of 4 mu m resisted dilation and could do so for up to 1 year. At 8 weeks, the 10 mu m pore graft had the highest density of cells in the electrospun layer and macrophages were the primary cell type present. This study highlights challenges in designing bioabsorbable TEAGs for the arterial environment in a large animal model. While larger pore diameter TEAGs promoted cell infiltration, neotissue could not regenerate rapidly enough to provide sufficient mechanical strength required to resist dilation. Future studies will be focused on evaluating a smaller pore design to better understand long-term remodeling and determine feasibility for clinical use. Statement of Significance In situ vascular tissue engineering relies on a biodegradable scaffold that encourages tissue regeneration and maintains mechanical integrity until the neotissue can bear the load. Species-specific differences in tissue regeneration and larger mechanical forces often result in graft failure when scaling up from small to large animal models. This study utilizes a slow-degrading electrospun PCL sheath to reinforce a tissue engineered arterials graft. Pore size, a property critical to tissue regeneration, was controlled by changing PCL fiber diameter and the resulting effects of these properties on neotissue formation and graft durability was evaluated. This study is among few to report the effect of pore size on vascular neotissue formation in a large animal arterial model and also demonstrate robust neotissue formation. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 50 条
  • [41] Development of in vivo Tissue-Engineered Vascular Grafts With an Ultra Small Diameter of 0.6 mm (MicroBiotubes)
    Ishii, Daizo
    Enmi, Jun-Ichiro
    Lida, Hidehiro
    Satow, Tetsu
    Takahashi, Jun C.
    Kurisu, Kaoru
    Nakayama, Yasuhide
    CIRCULATION, 2015, 132
  • [42] Construction of Tissue-Engineered Small-Diameter Vascular Grafts in Fibrin Scaffolds in 30 Days
    Gui, Liqiong
    Boyle, Michael J.
    Kamin, Yishai M.
    Huang, Angela H.
    Starcher, Barry C.
    Miller, Cheryl A.
    Vishnevetsky, Michael J.
    Niklason, Laura E.
    TISSUE ENGINEERING PART A, 2014, 20 (9-10) : 1499 - 1507
  • [43] PET/CT Imaging for Evaluating Inflammation in Rapamycin Coated Tissue-Engineered Arterial Grafts Implanted in an Ovine Model
    Chou, Ting-Heng
    Matsuzaki, Yuichi
    Iwaki, Ryuma
    Ulziibayar, Anudari
    Breuer, Christopher
    Shinoka, Toshiharu
    Stacy, Mitchel R.
    CIRCULATION, 2022, 146
  • [44] Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model - Discussions
    Vacanti, Joseph P.
    Kent, K. Craig
    Zenilman, Michael E.
    Breuer, Christopher K.
    ANNALS OF SURGERY, 2008, 248 (03) : 376 - 377
  • [45] A tissue-engineered suburethral sling in an animal model of stress urinary incontinence
    Cannon, TW
    Sweeney, DD
    Conway, DA
    Kamo, I
    Yoshimura, N
    Sacks, M
    Chancellor, MB
    BJU INTERNATIONAL, 2005, 96 (04) : 664 - 669
  • [46] Application of tissue-engineered bone grafts for alveolar cleft osteoplasty in a rodent model
    Korn, Paula
    Hauptstock, Maria
    Range, Ursula
    Kunert-Keil, Christiane
    Pradel, Winnie
    Lauer, Gunter
    Schulz, Matthias C.
    CLINICAL ORAL INVESTIGATIONS, 2017, 21 (08) : 2521 - 2534
  • [47] A Rat Model for the In Vivo Assessment of Biological and Tissue-Engineered Valvular and Vascular Grafts
    Sugimura, Yukiharu
    Schmidt, Anna Kathrin
    Lichtenberg, Artur
    Assmann, Alexander
    Akhyari, Payam
    TISSUE ENGINEERING PART C-METHODS, 2017, 23 (12) : 982 - 994
  • [48] Application of tissue-engineered bone grafts for alveolar cleft osteoplasty in a rodent model
    Paula Korn
    Maria Hauptstock
    Ursula Range
    Christiane Kunert-Keil
    Winnie Pradel
    Günter Lauer
    Matthias C. Schulz
    Clinical Oral Investigations, 2017, 21 : 2521 - 2534
  • [49] Long term functionality and growth of tissue-engineered living, autologous vascular grafts in a large animal model: the final step towards human application?
    Emmert, M. Y.
    Weber, B.
    Schmidt, D.
    Kelm, J.
    Jenni, R.
    Frauenfelder, T.
    Leschka, S.
    Falk, V.
    Zund, G.
    Hoerstrup, S. P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 80 - 80
  • [50] The Effect of Hypoxic Environment on the Enhancement of Collagen Content in Tissue-Engineered Vascular Grafts
    Lin, Zhanyi
    Xiao, Cong
    Xu, Jianyi
    Liu, Qin
    Sun, Xuheng
    Fang, Lijun
    Huanan Ligong Daxue Xuebao/Journal of South China University of Technology (Natural Science), 2025, 53 (01): : 129 - 135